Genetics, The Duchenne Registry and Your Family! Jen Ely, MS, CGC June 2, 2018

Similar documents
Understanding genetics, mutation and other details. Stanley F. Nelson, MD 6/29/18

How to go around conducting a clinical trial in small populations: Duchenne muscular dystrophy

Making a Plan and Lining Up Your Care Team. Kathi Kinnett, MSN, APRN SVP Clinical Care Amanda Weiglein, BSN, RN Manager Clinical Care

Gene therapy and genome editing technologies for the study and potential treatment of :

4th International Summer School on Rare Disease and Orphan Drug Registries. The Italian Duchenne and Becker Muscular Dystrophy Patients Registry

Mutation specific therapies

DMD Genetics: complicated, complex and critical to understand

Mutations. A2 Biology For WJEC

TREAT-NMD Neuromuscular Network

Paula Clemens NS-065/NCNP-01 Study Chair

Cardiac Health in Duchenne: What we are Learning from Cardiac MRI

Implementation of Newborn Screening for Duchenne Muscular Dystrophy.

X-linked Genetic Disorders

Muscular Dystrophy. Biol 405 Molecular Medicine

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW.

Exondys 51 (eteplirsen) injection Policy Number: Last Review: 10/2018 Origination: 10/2016 Next Review: 10/2019

Duchenne Newborn Screening in the U.S.

Genetics in Primary Care Curriculum Statement 6. Dr Dave Harniess PCME Stockport

Counsyl Foresight Carrier Screen. Utmost confidence in every result

DSS-1. No financial disclosures

DNA Basics. We are all made up of cells. Cells contain DNA, or instructions to tell our bodies how to work.

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Highly Specialised Technology Evaluation

ICARE Initiative. Cristi Radford, MS, CGC ICARE Outreach Coordinator

Inheritance and the muscular dystrophies

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY

Corporate Medical Policy

TREAT-NMD Conference 2013

Clinical Policy: Eteplirsen Reference Number: NH.PHAR.288 Effective Date: 12/16

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY

Lecture 17: Human Genetics. I. Types of Genetic Disorders. A. Single gene disorders

Decision making Barriers and Facilitators for Pediatric Neuromuscular Clinical Trials. Barbara Bowles Biesecker, PhD, MS April 1, 2016

Bringing Differentiated Therapies to Duchenne Patients Stuart Peltz, PhD

Genetics and Genetic Testing for Autism:

Human beings contain tens of thousands of genes, the basic material for cell

MOLECULAR DIAGNOSIS for X-LINKED INTELLECTUAL DISABILITY

14 2 Human Chromosomes

Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

DNA is the genetic material that provides instructions for what our bodies look like and how they function. DNA is packaged into structures called

Benefits and pitfalls of new genetic tests

Southeast Regional Office 2870 Peachtree Road, PMB 196 Atlanta, Georgia 30305

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report

Sequencing. Deletion/Duplication Analysis. How Does Genetic Testing for Cancer Work?

Gene Therapy With a Difference By ANDREW POLLACK

Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy)

Chapter 12-4 DNA Mutations Notes

Expanded Carrier Screening: What s Best?

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

See Important Reminder at the end of this policy for important regulatory and legal information.

A Genetic Overview of Hypophosphatasia

Epilepsy Genetics Service Kings College Hospital & St Thomas s Hospital, London

Action Duchenne Conference London, 2 nd -4 th November 2007

Subject: Eteplirsen (Exondys 51)

Genetics & CMT Q&A Questions from the CMTA Genetics & CMT Discussion Forum

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN

110 DISEASES 3 DISEASES GENE TIC COUNSELING CARRIERMAP Recombine. Others. 30+ minute clinical genetic counseling session.

Introduction to Genetics

BAI Beacon The Newsletter from Family and Community Services

CARE CONSIDERATIONS FOR DUCHENNE MUSCULAR DYSTROPHY

Capricor Therapeutics

GENETICS ROTATION OBJECTIVES MATERNAL-FETAL MEDICINE FELLOWSHIP

Translating Science. Transforming Lives. ACT DMD Clinical Trial Results

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center

Cover Page. The handle holds various files of this Leiden University dissertation.

PRE-PREGNANCY CARRIER SCREENING. What is it, how does it work and should future parents consider it?

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

TREAT-NMD Partner Newsletter No th June 2007 and Club of Interest Newsletter No. 11

Duchenne in 2013 DUCHENNE IN Cape Town, February 2013

AMERICAN BOARD OF MEDICAL GENETICS AND GENOMICS

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology

DOSING & ADMINISTRATION GUIDE

Slide 1: The information has been produced with thanks to the NHS Newborn Blood Spot Screening Programme.

The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice

IBMPFD Educational Information For Patients and Families

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology

Risk assessment and genetic counseling in families with Duchenne muscular dystrophy

Data Collection Methods to Improve Quality Control. CNDR Innovation At Work

DOSING & ADMINISTRATION GUIDE

Lab Activity Report: Mendelian Genetics - Genetic Disorders

Gene Expression and Mutation

Section Chapter 14. Go to Section:

Clinical Policy Title: Genetic tests for Duchenne muscular dystrophy

X Linked Inheritance. Information for Patients and Families. Illustrations by Rebecca J Kent

Welcome & Global Genes Mission in Action

Spinal Muscular Atrophy as a Focus Indication for Biomarker Development. Meg Winberg, PhD Spinal Muscular Atrophy Foundation February 26, 2007

Accessing EMFLAZA (deflazacort) for Duchenne muscular Dystrophy PPMD 2017 Connect Conference June 29, 2017; 4:00pm Stuart Peltz, PhD PTC

How many disease-causing variants in a normal person? Matthew Hurles

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Genetic Counseling. Brook Croke, MS, MPH Genetic Counselor (cell)

Human inherited diseases

Protocol. Genetic Testing for Duchenne and Becker Muscular Dystrophy

THE CHROMOSOMAL BASIS OF INHERITANCE CHAPTER 15

Transforming the Future for Deaf & Hard of Hearing Students 2019 Scholarship Program Application for First-Time Applicants

New Drug Evaluation: Eteplirsen injection, intravenous

ICD-10-CM Code Refinement: for Duchenne/Becker MD & FSHD

See Important Reminder at the end of this policy for important regulatory and legal information.

Emory Preparedness and Emergency Response Research Center H1N1 Survey of Healthcare Workers in Correctional Facilities

Reproductive carrier screening

Administer as an intravenous infusion over 35 to 60 minutes (2.1, 2.3) Dilution required prior to administration (2.2)

Transcription:

Genetics, The Duchenne Registry and Your Family! Jen Ely, MS, CGC June 2, 2018

The Duchenne Registry Team Two Genetic Counselors to help you: Ann Martin, MS, CGC Jen Ely, MS, CGC Registry also supported by: Amanda Weiglein, BSN Liz Habeeb-Louks

Topics for Today: 1. Importance of genetics in Duchenne and Becker 2. Free genetic testing through Decode Duchenne 3. Connecting to research through The Duchenne Registry 4. Answer your questions!

Role of Genetic Counselor Coordinate genetic testing Interpret results Educate family regarding prognosis, recurrence risk and prenatal testing Discuss carrier testing for female relatives Recommend resources, support & research

How genetics shapes the story And 3 reasons why testing is important Genetic testing is the gold standard for diagnosis Diagnosis Family Results help other family members get testing Mutation-specific therapies are in development Research

Genetics Review

X-linked Recessive Inheritance

Background: the DMD gene The DMD has 79 exons but what is an exon? DMD gene sequence Dystrophin protein

Types of Changes in the DMD gene More than 4000 unique genetic changes Fall into categories Type of Change % of Duchenne cases % of Becker cases Large deletions 60-70% 80-85% Large duplications 10% 5-10% Point mutations and other small changes 15-30% 10-15%

Types of Genetic Mutations

Large deletions and duplications One or more exons missing or extra

Out-of-frame vs. In-frame Letters in the DNA sequence must stay in groups of three: AAC ATG CGG TAC Example sentence: THE OLD DOG RAN TOO FAR Out-of-frame deletion: THE OLD DOG RAN TOO FAR THL DDO GRA NTO OFA R Duchenne In-frame deletion: THE OLD DOG RAN TOO FAR THE OLD RAN TOO FAR Becker

Why is the type of genetic variant so important? 1. Helps to confirm the diagnosis 2. Essential for coordinating testing of family members 3. Critical for mutation-specific research new strategies target the DNA problem at the source

Mutation-Specific Therapies For Nonsense mutations: Nonsense mutation read-through PTC Therapeutics (Translarna ) For Deletions: Exon skipping Sarepta Therapeutics (exon 51, 45, and 53 skipping Exondys 51, SRP-4045, SRP-4053) NS Pharma (exon 53 skipping - NS-065/NCNP-01) Wave Life Sciences (exon 51 skipping - WVE-210201)

New Website Launched in April!

Duchenne Deletion Tool

Duchenne Deletion Tool

Criteria for Free Testing: Have a confirmed or suspected diagnosis of Duchenne or Becker muscular dystrophy OR Are a symptom free female of a relative with Duchenne or Becker with a known mutation from previous DNA testing Have never had genetic testing OR previous genetic testing has not confirmed a mutation Have a financial barrier Legal resident of US or Canada All testing performed at:

Carrier testing As of April 1 st we will be providing free carrier testing through Decode Duchenne! We can work directly with you or your local health care provider. We are available to answer your questions: What do my test results mean For my health? For my future pregnancies? For my relatives? Contact us! coordinator@duchenneregistry.org or 888-520-8675

Over 1,000 participants to date in the Decode Duchenne program!

New Registry Website Launched in April!

The Duchenne Registry (formerly DuchenneConnect) Online self-report registry and resource for individuals with Duchenne or Becker, as well as carrier females Established by PPMD in 2007, in collaboration with the NIH, CDC and Emory Genetics 4,000+ registrants DuchenneRegistry.org

International Registry

Goal of Duchenne Registry To educate and connect the entire Duchenne and Becker community, including individuals with Duchenne and Becker, their families, healthcare providers and researchers.

What We Do Education Website, newsletters, email blasts, social media, webinars Recruitment In 2017, recruited for 8 clinical trials and 11 research studies The Duchenne Registry Genetic Testing Decode Duchenne genetic testing program Advance Research In 2017, provided data to 9 institutions (5 industry)

The Duchenne Registry: Working Together to Advance Research New trials begin You New research ideas generated Researchers Genetic Test Report Medical Surveys We notify you about research opportunities and important news We can provide support specific to you Demographics We review and curate data We help develop new research ideas Data shared with qualified researchers and global registry Your Duchenne Registry Data Our Team Industry Data Provided for trial planning

Research > Clinical Trials

Please Register Today! The majority of clinical trials & research studies recruit through the Registry Complete the Medical History surveys to get the most appropriate information for you The surveys are short and you will be entered into a raffle for a NEW ipad!

ipad Winners!

Your Data Makes a Difference Register Today! www.duchenneregistry.org coordinator@duchenneregistry.org 888-520-8675